由生命早期低剂量抗生素暴露引起的IgA功能障碍加剧了饮食诱导的代谢综合征
Xue Han1,2, Yue Qin2, Jielong Guo2
1State Key Laboratory of Vascular Homeostasis and Remodeling, Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
Antibiotics (Basel, Switzerland)
|June 25, 2025
概括
早期暴露于低剂量的青素 (LDP) 破坏了肠道微生物群,导致免疫缺陷,并加剧了小鼠的代谢综合征 (MetS). 这突显了早期抗生素使用与长期代谢健康之间的关键联系.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 代谢健康 代谢健康
背景情况:
- 动物料中低剂量抗生素污染会造成食品安全风险.
- 早期暴露于低剂量青素 (LDP) 与代谢综合征 (MetS) 有关,但机制尚不清楚.
研究的目的:
- 研究肠道微生物群 (GM) 和肠道免疫在调解LDP长期代谢效应中的作用.
- 确定早期的LDP暴露是否会导致转基因和免疫反应的持续变化.
主要方法:
- 小鼠在生命早期暴露于LDP.
- 分析了转基因成分,肠道IgA反应,细菌侵占和炎症.
- 使用无细菌小鼠进行转基因移植实验,以测试因果关系.
主要成果:
- 早期的LDP暴露扰乱了叶叶转基因,并持续抑制了肠道IgA反应.
- 减少细菌的IgA结合导致侵占和炎症的增加.
- 这些变化加剧了饮食引起的MetS.
结论:
- 早期的LDP暴露会导致持续的转基因破坏和IgA缺乏,导致炎症并加剧MetS.
- 由转基因破坏引发的肠道SIgA依赖性途径,将早期的抗生素暴露与代谢功能障碍联系起来.
- 这些发现对食品安全和了解早期抗生素暴露对健康的长期影响有重大影响.
相关概念视频
Irritable Bowel Syndrome I: Introduction
360
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
360
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
201
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
201
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
407
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
407
Drugs for Treatment of Diarrhea-Predominant IBS
289
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
289
Other Disorders of Digestive System
996
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
996
Drugs for Treatment of Constipation-Predominant IBS
322
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
322


